Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis
Open Access
- 14 April 2005
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 19 (6) , 1029-1033
- https://doi.org/10.1038/sj.leu.2403745
Abstract
To elucidate whether reduced-intensity conditioning (RIC) decreases treatment-related mortality (TRM) after allogeneic stem cell transplantation (allo-SCT) for chronic lymphocytic leukemia (CLL), we retrospectively compared 73 RIC cases from a recent EBMT survey with 82 patients from the EBMT database who had undergone standard myeloablative conditioning (MC) for CLL during the same time period. The two populations were matched by adjusting the primary risk factor, the conditioning regimen, in a series of Cox models for age, sex, donor type, remission status at transplant and analyzed for its effect on TRM, relapse incidence, event-free (EFS) and overall survival (OS). After adjustment, a significant reduction of TRM became evident for the RIC population (hazard ratio (HR) 0.4 (95% confidence interval 0.18–0.9); P=0.03). On the other hand, RIC was associated with an increased relapse incidence (HR 2.65 (0.98–7.12); P=0.054). There was no significant difference between RIC and MC in terms of EFS (HR 0.69 (0.38–1.25); P=0.22) and OS (HR 0.65 (0.33–1.28); P=0.21). We conclude that RIC appears to favorably influence TRM after allo-SCT for CLL. This observation, as well as possible detrimental effects of RIC on relapse risk, should be confirmed by prospective studies.Keywords
This publication has 19 references indexed in Scilit:
- BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsBlood, 2004
- Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study GroupJournal of Clinical Oncology, 2003
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2003
- Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioningLeukemia, 2003
- Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow TransplantationBlood, 2002
- Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disordersBlood, 2002
- Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemiaLeukemia, 2002
- Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemiaBone Marrow Transplantation, 2002
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaBone Marrow Transplantation, 2000